Dr Reddys launches heartburn OTC tablet in US Dr Reddys launches heartburn OTC tablet in US DSIJ Intelligence / Tuesday, December 11, 2018 0 1314 Article rating: 5.0 The pharma major launched omeprazole delayed-release tablets, 20 mg, an over-the-counter (OTC) equivalent of Prilosec OTC in the US market. This has helped the stock trade in the green in an otherwise volatile market on Tuesday. Read more
Rupee down by 1.6 per cent, bonds skid Rupee down by 1.6 per cent, bonds skid DSIJ Intelligence / Tuesday, December 11, 2018 0 885 Article rating: 5.0 The rupee and bonds plunged as Reserve Bank of India Governor, Urjit Patel resigned post market hours on Monday, surprising many investors. Concerns about mixed results from crucial state elections also kept traders wary during Tuesday's trading session. Read more
Five stocks with selling interest Five stocks with selling interest Shital Jibhe / Tuesday, December 11, 2018 0 1414 Article rating: 5.0 Overall volumes in futures & options currently stand at 78, 93,174 contracts with a turnover of Rs. 4, 79,808.70 crore. Read more
Five stocks with buying interest Five stocks with buying interest Shital Jibhe / Tuesday, December 11, 2018 0 1330 Article rating: 5.0 Overall volumes in futures & options currently stand at 78, 93,174 contracts with a turnover of Rs. 4, 79,808.70 crore. Read more
Strides Pharma JV gets approval for anthelmintic tablets Strides Pharma JV gets approval for anthelmintic tablets Nidhi Jani / Tuesday, December 11, 2018 0 686 Article rating: 5.0 Strides Pharma Science Limited's 50:50 JV Strides Vivimed has got USFDA approval for Albendazole Tablets on Tuesday. The US market for the said tablets is around US$100mn as per IQVIA MAT data. Read more